Figure 1From: Equipoise, design bias, and randomized controlled trials: the elusive ethics of new drug developmentThe drug development sequence. Note that the drug sponsor accumulates large amounts of data about the drug, and has eliminated the least promising agents before the design process for randomized controlled trials occurs.Back to article page